DRUG-seq Provides Unbiased Biological Activity Readouts for Drug Discovery
Jingyao Li(Shanghai University), Robert J. Ihry(Genomics Institute of the Novartis Research Foundation), Tayfun Tumkaya, Robin Ge, Chian Yang, Daniel Ho(Novartis (United States)), Caroline Gubser Keller(Novartis (Switzerland)), Marc Hild(Pathways Behavioral Services), Kathleen A. Worringer(Johns Hopkins University), Frederic Sigoillot(Novartis (China)), Alicia Lindeman, Leandra Mansur, Martin Hénault, Steffen Renner(Novartis (Switzerland)), Marilisa Neri(Novartis (Switzerland)), Carsten Russ(Broad Institute), Jeremy L. Jenkins(National Laboratory of the Rockies)
Cited by 1
Related Papers
A Draft Sequence of the Neandertal Genome
|Science|2010|4.6k
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing
|Nature Biotechnology|2009|1.5k
Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries
|Genome biology|2011|1.2k